Mesa Laboratories Inc: Form 10-Q for the period ended Jun 30, 2017
Filed with the SEC on Aug 1, 2017 and accepted by EDGAR at Aug 1, 2017, 08:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2017-04-01 to 2017-06-30 | $10.0m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2017-04-01 to 2017-06-30 | $12.7m | us-gaap:GrossProfit |
| Research and development | 3 months2017-04-01 to 2017-06-30 | $1.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2017-04-01 to 2017-06-30 | $2.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2017-04-01 to 2017-06-30 | −$214.0k | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months2017-04-01 to 2017-06-30 | $0.39 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-04-01 to 2017-06-30 | $0.41 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-04-01 to 2017-06-30 | 3,923,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Dividends paid | 3 months2017-04-01 to 2017-06-30 | $601.0k | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2017-06-30 | $3.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-06-30 | $33.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-06-30 | $169.0m | us-gaap:Assets |
| Current liabilities | At period end2017-06-30 | $14.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-06-30 | $68.0m | us-gaap:Liabilities |
| Long-term debt | At period end2017-06-30 | $49.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2017-06-30 | $1.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2017-06-30 | $101.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-17-013423. Last ingested by Listed: Nov 13, 2026, 07:45 ET. Listed shows no prices and gives no investment advice.